ID   MCPS_PSEPK              Reviewed;         639 AA.
AC   Q88E10;
DT   22-JAN-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   07-APR-2021, entry version 98.
DE   RecName: Full=Methyl-accepting chemotaxis protein McpS;
GN   Name=mcpS; OrderedLocusNames=PP_4658;
OS   Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=160488;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=12534463; DOI=10.1046/j.1462-2920.2002.00366.x;
RA   Nelson K.E., Weinel C., Paulsen I.T., Dodson R.J., Hilbert H.,
RA   Martins dos Santos V.A.P., Fouts D.E., Gill S.R., Pop M., Holmes M.,
RA   Brinkac L.M., Beanan M.J., DeBoy R.T., Daugherty S.C., Kolonay J.F.,
RA   Madupu R., Nelson W.C., White O., Peterson J.D., Khouri H.M., Hance I.,
RA   Chris Lee P., Holtzapple E.K., Scanlan D., Tran K., Moazzez A.,
RA   Utterback T.R., Rizzo M., Lee K., Kosack D., Moestl D., Wedler H.,
RA   Lauber J., Stjepandic D., Hoheisel J., Straetz M., Heim S., Kiewitz C.,
RA   Eisen J.A., Timmis K.N., Duesterhoeft A., Tuemmler B., Fraser C.M.;
RT   "Complete genome sequence and comparative analysis of the metabolically
RT   versatile Pseudomonas putida KT2440.";
RL   Environ. Microbiol. 4:799-808(2002).
RN   [2]
RP   FUNCTION, SUBUNIT, DISRUPTION PHENOTYPE, AND GENE NAME.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=20498372; DOI=10.1074/jbc.m110.110403;
RA   Lacal J., Alfonso C., Liu X., Parales R.E., Morel B., Conejero-Lara F.,
RA   Rivas G., Duque E., Ramos J.L., Krell T.;
RT   "Identification of a chemoreceptor for tricarboxylic acid cycle
RT   intermediates: differential chemotactic response towards receptor
RT   ligands.";
RL   J. Biol. Chem. 285:23126-23136(2010).
RN   [3]
RP   FUNCTION, AND ACTIVITY REGULATION.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=21360620; DOI=10.1002/jmr.1101;
RA   Lacal J., Garcia-Fontana C., Callejo-Garcia C., Ramos J.L., Krell T.;
RT   "Physiologically relevant divalent cations modulate citrate recognition by
RT   the McpS chemoreceptor.";
RL   J. Mol. Recognit. 24:378-385(2011).
RN   [4]
RP   METHYLATION BY CHER2.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=23677992; DOI=10.1074/jbc.m113.472605;
RA   Garcia-Fontana C., Reyes-Darias J.A., Munoz-Martinez F., Alfonso C.,
RA   Morel B., Ramos J.L., Krell T.;
RT   "High specificity in CheR methyltransferase function: CheR2 of Pseudomonas
RT   putida is essential for chemotaxis, whereas CheR1 is involved in biofilm
RT   formation.";
RL   J. Biol. Chem. 288:18987-18999(2013).
RN   [5]
RP   CRYSTALLIZATION OF 47-283.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=22505412; DOI=10.1107/s1744309112004940;
RA   Gavira J.A., Lacal J., Ramos J.L., Garcia-Ruiz J.M., Krell T.,
RA   Pineda-Molina E.;
RT   "Crystallization and crystallographic analysis of the ligand-binding domain
RT   of the Pseudomonas putida chemoreceptor McpS in complex with malate and
RT   succinate.";
RL   Acta Crystallogr. F 68:428-431(2012).
RN   [6] {ECO:0007744|PDB:2YFA, ECO:0007744|PDB:2YFB}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 46-283 IN COMPLEX WITH
RP   (S)-MALATE; SUCCINATE AND ACETATE, SUBUNIT, AND MUTAGENESIS OF ARG-60;
RP   ARG-63; ARG-183 AND ARG-254.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=23112148; DOI=10.1073/pnas.1201400109;
RA   Pineda-Molina E., Reyes-Darias J.A., Lacal J., Ramos J.L.,
RA   Garcia-Ruiz J.M., Gavira J.A., Krell T.;
RT   "Evidence for chemoreceptors with bimodular ligand-binding regions
RT   harboring two signal-binding sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:18926-18931(2012).
CC   -!- FUNCTION: Chemotactic-signal transducers respond to changes in the
CC       concentration of attractants and repellents in the environment,
CC       transduce a signal from the outside to the inside of the cell, and
CC       facilitate sensory adaptation through the variation of the level of
CC       methylation. McpS is a specific chemoreceptor for 6 tricarboxylic acid
CC       (TCA) cycle intermediates (succinate, fumarate, malate, oxaloacetate,
CC       citrate and isocitrate), butyrate and acetate. Malate, succinate,
CC       fumarate and oxaloacetate cause the strongest chemotactic response.
CC       {ECO:0000269|PubMed:20498372, ECO:0000269|PubMed:21360620}.
CC   -!- ACTIVITY REGULATION: Binding of citrate to the ligand-binding domain
CC       reduces the chemotaxis towards the strong attractants such as malate
CC       and succinate. However, in physiologically relevant niches, citrate is
CC       mostly complexed with magnesium or calcium ions, and does not bind
CC       McpS. {ECO:0000269|PubMed:21360620}.
CC   -!- SUBUNIT: Homodimer. Exists as a mixture of monomers and dimers in
CC       solution. Ligand binding stabilizes the dimeric form.
CC       {ECO:0000269|PubMed:20498372, ECO:0000269|PubMed:23112148}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- PTM: Methylated by CheR2. {ECO:0000269|PubMed:23677992}.
CC   -!- DISRUPTION PHENOTYPE: Mutant fails to respond to succinate but responds
CC       to toluene. {ECO:0000269|PubMed:20498372}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE015451; AAN70231.1; -; Genomic_DNA.
DR   RefSeq; NP_746767.1; NC_002947.4.
DR   RefSeq; WP_010955314.1; NC_002947.4.
DR   PDB; 2YFA; X-ray; 1.80 A; A/B=46-283.
DR   PDB; 2YFB; X-ray; 1.90 A; A/B=46-283.
DR   PDBsum; 2YFA; -.
DR   PDBsum; 2YFB; -.
DR   SMR; Q88E10; -.
DR   DIP; DIP-60088N; -.
DR   STRING; 160488.PP_4658; -.
DR   EnsemblBacteria; AAN70231; AAN70231; PP_4658.
DR   KEGG; ppu:PP_4658; -.
DR   PATRIC; fig|160488.4.peg.4966; -.
DR   eggNOG; COG0840; Bacteria.
DR   HOGENOM; CLU_000445_107_27_6; -.
DR   OMA; IDRSNWM; -.
DR   BioCyc; PPUT160488:G1G01-4971-MONOMER; -.
DR   Proteomes; UP000000556; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0006935; P:chemotaxis; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IEA:UniProtKB-KW.
DR   InterPro; IPR004090; Chemotax_Me-accpt_rcpt.
DR   InterPro; IPR003660; HAMP_dom.
DR   InterPro; IPR032255; HBM.
DR   InterPro; IPR004089; MCPsignal_dom.
DR   Pfam; PF00672; HAMP; 1.
DR   Pfam; PF16591; HBM; 1.
DR   Pfam; PF00015; MCPsignal; 1.
DR   PRINTS; PR00260; CHEMTRNSDUCR.
DR   SMART; SM00304; HAMP; 2.
DR   SMART; SM01358; HBM; 1.
DR   SMART; SM00283; MA; 1.
DR   PROSITE; PS50111; CHEMOTAXIS_TRANSDUC_2; 1.
DR   PROSITE; PS50885; HAMP; 1.
DR   PROSITE; PS51753; HBM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Chemotaxis; Coiled coil; Membrane;
KW   Methylation; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..639
FT                   /note="Methyl-accepting chemotaxis protein McpS"
FT                   /id="PRO_0000424826"
FT   TOPO_DOM        1..13
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        14..34
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        35..288
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        289..309
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        310..639
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          41..283
FT                   /note="HBM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01089"
FT   DOMAIN          310..362
FT                   /note="HAMP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00102"
FT   DOMAIN          367..603
FT                   /note="Methyl-accepting transducer"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00284"
FT   REGION          60..65
FT                   /note="(S)-malate binding"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA"
FT   REGION          60..65
FT                   /note="Succinate binding"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFB"
FT   COILED          191..245
FT                   /evidence="ECO:0000255"
FT   BINDING         138
FT                   /note="Acetate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA, ECO:0007744|PDB:2YFB"
FT   BINDING         183
FT                   /note="Acetate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA, ECO:0007744|PDB:2YFB"
FT   BINDING         187
FT                   /note="Acetate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA, ECO:0007744|PDB:2YFB"
FT   BINDING         236
FT                   /note="Acetate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA, ECO:0007744|PDB:2YFB"
FT   BINDING         254
FT                   /note="(S)-malate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA"
FT   BINDING         254
FT                   /note="Succinate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFB"
FT   BINDING         258
FT                   /note="(S)-malate"
FT                   /evidence="ECO:0000269|PubMed:23112148,
FT                   ECO:0007744|PDB:2YFA"
FT   MUTAGEN         60
FT                   /note="R->A: Abolishes binding of malate, fumarate,
FT                   oxaloacetate, succinate, isocitrate and butyrate. Decreases
FT                   binding of citrate."
FT                   /evidence="ECO:0000269|PubMed:23112148"
FT   MUTAGEN         63
FT                   /note="R->A: Abolishes binding of malate, fumarate,
FT                   oxaloacetate, succinate, isocitrate and butyrate. Decreases
FT                   binding of citrate."
FT                   /evidence="ECO:0000269|PubMed:23112148"
FT   MUTAGEN         183
FT                   /note="R->A: Decreases binding of acetate. Does not affect
FT                   binding of malate."
FT                   /evidence="ECO:0000269|PubMed:23112148"
FT   MUTAGEN         254
FT                   /note="R->A: Abolishes binding of malate, fumarate,
FT                   oxaloacetate, succinate and isocitrate. Decreases binding
FT                   of citrate. Does not affect binding of butyrate."
FT                   /evidence="ECO:0000269|PubMed:23112148"
FT   HELIX           46..68
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   TURN            69..71
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   HELIX           73..96
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   HELIX           100..157
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   HELIX           162..191
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   HELIX           195..218
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   HELIX           220..222
FT                   /evidence="ECO:0007744|PDB:2YFA"
FT   HELIX           223..276
FT                   /evidence="ECO:0007744|PDB:2YFA"
SQ   SEQUENCE   639 AA;  68764 MW;  827C3ADD979A87DB CRC64;
     MNSWFANISV NLKLGLGFGL VLVLTGLLAL TGWTSLGSLI DRSNWMGDIG QLNKDLTDLR
     IARLQYMIAN GDDTAAANTL AKLDAFSKQQ AYLATTFKSP ENVKLLGELG DTISAYKLSL
     NKMRQGYDAT RAARVSMDSS AIRADQAMDA LSQEVMARPE ADSVRLAQYQ LISKARQQLL
     QVRIDVRGYI AENSSANEQA ALRQLDAALA DTDNLKRQLP SEDARLQQFE NAVLAYRDAV
     RQFRDAVANI TTSRAEMTVQ GADIVKRSDA LYQIQLERRD IESTQARSLQ AIATLLALLV
     GVLAAVLITR QITRPLQDTL VAVEKIASGD LTQHMRVTRR DELGVLQQGI ARMGTTLREL
     ISGIRDGVTQ IASAAEELSA VTEQTSAGAN SQKVETDQVA TAMHEMAATV QEVARNAEQA
     SHAATGADDE ARAGDRVVGE AIGQIERLAE DMHRSTEAMN LLQQESQKIG SVMDVIKSVA
     EQTNLLALNA AIEAARAGEA GRGFAVVADE VRGLAQRTQK STEEIEELIA SLQHGTQQVA
     NAMQGSRALT DSSVELARKA GSSLESITST VSSIQSMNQQ IAAAAEQQSA VAEEISRSIL
     NVRDVSEQTA AASDETAASS VELARLGGQL QTLVSQFRV
//
